Accounts Submission

Accounts Submission

PARDONTHENONSENSE LIMITED - Company Information

Print Friendly Version

PARDONTHENONSENSE LIMITED

Company Registration Number:
09677376 (England and Wales)

Unaudited abridged accounts for the year ended 30 June 2021

Period of accounts

Start date: 01 August 2020

End date: 30 June 2021

Page 1

PARDONTHENONSENSE LIMITED

Contents of the Financial Statements

for the Period Ended 30 June 2021

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

Page 2

PARDONTHENONSENSE LIMITED

Company Information

for the Period Ended 30 June 2021




Director: Megan Prendergast
Registered office: Flat 4
16 St Catherine's Terrace
Hove
East Sussex
GBR
BN3 2RH
Company Registration Number: 09677376 (England and Wales)

Page 3

PARDONTHENONSENSE LIMITED

Directors' Report Period Ended 30 June 2021

The directors present their report with the financial statements of the company for the period ended 30 June 2021

Principal Activities

The companies principle activity is to provide veterinary services to veterinary businesses.

Directors

The directors shown below have held office during the whole of the period from 01 August 2020 to 30 June 2021
Megan Prendergast

This report was approved by the board of directors on 2 July 2021
And Signed On Behalf Of The Board By:

Name: Megan Prendergast
Status: Director

Page 4

PARDONTHENONSENSE LIMITED

Profit and Loss Account

for the Period Ended 30 June 2021


Notes		 11 months to
30 Jun 2021
£
2020
£
Gross Profit or (Loss) 13,253 -
Distribution Costs ( 1,849 ) -
Administrative Expenses ( 1,125 ) -
Operating Profit or (Loss) 10,279 -
Profit or (Loss) Before Tax 10,279 -
Profit or (Loss) for Period 10,279 -

The notes form part of these financial statements

Page 5

PARDONTHENONSENSE LIMITED

Balance sheet

As at 30 June 2021


Notes		 11 months to
30 Jun 2021
£
2020
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 9,756 6,034
Total current assets: 9,756 6,034
Creditors: amounts falling due within one year: ( 9,754 ) ( 6,032 )
Net current assets (liabilities): 2 2
Total assets less current liabilities: 2 2
Provision for liabilities: ( 0 )
Total net assets (liabilities): 2 2

The notes form part of these financial statements

Page 6

PARDONTHENONSENSE LIMITED

Balance sheet continued

As at 30 June 2021


Notes		 11 months to
30 Jun 2021
£
2020
£
Capital and reserves
Called up share capital: 2 2
Shareholders funds: 2 2

For the year ending 30 June 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 2 July 2021
And Signed On Behalf Of The Board By:

Name: Megan Prendergast
Status: Director

The notes form part of these financial statements

Page 7

PARDONTHENONSENSE LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2021

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Page 8

PARDONTHENONSENSE LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2021

  • 2. Employees

    11 months to
    30 Jun 2021
    2020
    Average number of employees during the period 1 1

Page 9

PARDONTHENONSENSE LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2021

  • 3. Off balance sheet disclosure

    No

Page 10